Biovail Focus Is Product Development After Divesting Primary Care Sales Reps
Executive Summary
Biovail will focus on "recharging its drug development portfolio" as the company moves forward after divesting its primary care sales force, Senior VP-R&D Gregory Szpunar said May 5